Search

Your search keyword '"Nainu, Firzan"' showing total 461 results

Search Constraints

Start Over You searched for: Author "Nainu, Firzan" Remove constraint Author: "Nainu, Firzan"
461 results on '"Nainu, Firzan"'

Search Results

5. Herbal Medicines

6. Brain Diseases

7. Zebrafish as a model organism for virus disease research: Current status and future directions

8. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

9. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021

12. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

13. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

14. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

15. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

16. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

17. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

18. Apoptosis and Phagocytosis as Antiviral Mechanisms

22. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

23. Natural polymers as potential P-glycoprotein inhibitors: Pre-ADMET profile and computational analysis as a proof of concept to fight multidrug resistance in cancer

24. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

25. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

29. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies

31. New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review

32. Skin microbiome profile of healthy Cameroonians and Japanese

35. Phytoconstituents of Citrus limon (Lemon) as Potential Inhibitors Against Multi Targets of SARS‐CoV‐2 by Use of Molecular Modelling and In Vitro Determination Approaches.

36. Fractionation of ethanol extract of sesewanua leaves (Clerodendrum fragrans wild.) in n-hexane : Ethyl acetate and their antioxidant activity.

39. Health promoting benefits of pongamol: An overview

40. SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies–a narrative review

42. A fruit fly-based approach to unraveling enteropathy-causing pharmaceuticals

43. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

44. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

45. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

46. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

47. Curcumin-mediated alleviation of dextran-induced leaky gut in Drosophila melanogaster

48. Effects of tobacco smoke on the expression of virulence genes in Escherichia coli

49. Gut Microbiota Dynamics and Phenotypic Changes Induced by Tetracycline in Drosophila melanogaster.

Catalog

Books, media, physical & digital resources